BIOTECHNOLOGY

CONTENTS

• Biotechnology : Introduction

• Biotechnology industry in India

• How can Biotechnology be used to address various issues in India?

• Challenges faced in India

• Genetic Engineering

• Assisted Reproduction Technology

• Recombinant DNA (rDNA)

• Cloning Vectors

• Competent Host – Methods to Induce Alien DNA into Host Cells

• Biotechnology and Its Applications

• Global spread of GM crops

• Concern with GM Varieties

• Regulatory Challenges

• Biotechnology: Ethical Issues

• Biotechnological applications in medicine

• Bio fortification of crops

• Biotechnology deals with techniques of using live organisms or enzymes from organisms to produce products and processes useful to humans.
• Making curd, bread or wine, which are all microbe-mediated processes, could also be thought as a form of biotechnology.
• However, it is used in a restricted sense today, to refer to such of those processes which use genetically modified organisms to achieve the same on a larger scale.
• Modern biotechnology using genetically modified organisms was made possible only when man learnt to alter the chemistry of DNA and construct recombinant DNA. This key process is called recombinant DNA technology or genetic engineering.
• This process involves the use of restriction endonucleases, DNA ligase, appropriate plasmid or viral vectors to isolate and ferry the foreign DNA into host organisms, expression of the foreign gene, purification of the gene product, i.e., the functional protein and finally making a suitable formulation for marketing. Large scale production involves use of bioreactors.
• Biotechnology is the area of biology that uses living processes, organisms or systems to manufacture products or technology intended to improve the quality of human life.
• It includes disciplines like molecular modelling, genomic, bio – informatics, bio – simulation, clinical information and many more.
• It provides breakthrough products and technologies to combat debilitating and rare diseases, reduce our environmental footprint, feed the hungry, use less and cleaner energy, and have safer, cleaner and more efficient industrial manufacturing processes.
• The various branches of Biotechnologyinclude-Blue biotechnology (marine and aquatic application), green biotechnology (agriculture processes), red biotechnology (medical) and white biotechnology (industrial).

• India is among the top 12 destinations for biotechnology in the world, with approximately 2% share in the global Biotechnology industry.
• The biopharmaceutical sector accounts for the largest share of the biotech industry in India with a share of 55% of total revenues, followed by Bio-Agri with 22% market share (2018).
• The high demand for different biotech products has also opened up scope for the foreign companies to set up base in India.
• India has emerged as a leading destination for clinical trials, contract researchand manufacturing activities owing to the growth in the bio-services sector.

• Food security: Biotechnology can help make crops more productive and tolerant of other stress like pest, insect etchelping to feed the next billion people.
  • Foods can also deliver enhanced nutrition, such as Golden Rice with additional vitamin A from the International Rice Research Institute.
  • Making crops resistant to pest attacks (Bt Cotton and Bt Brinjal).
• Adapting to Climate change: Biotechnology industry is helping to produce crops that are resistant to the effects of climate change, help farmers convert to no-till practices and develop solutions that decrease carbon-based fertilizers
• Tackling diseases: to threats like Zika virus and the rise of antibiotic- resistant bacteria. Usage of stem cell therapy offers a
• Bioenergy: There has been increase in use of bioethanol and biodiesels in India. These fuels are derived from
• Living organisms such as plants and their by-products, microbes or animal waste. The growing energy needs of India’s rural areas have been increasingly met by biomass fuel.
• Tackling diseases and advancement in drugs:Biotechnology offers new solution to various diseases through technologies such as stem cell therapy.
• Livestock improvement :Biotechnological techniques such as embryo transfer technology are used to improve the productivity of live stock and also for development of affordable new generation vaccines and diagnostics against a plethora of animal diseases.
• Waste management: through techniques like bioremediation.

• Low Research and development: India’s research and development expenditure is quite low at 0.67 per cent of GDP, not only compared to mature biotechnology economies such as Japan and the US (which stands at around 3 per cent) but also in comparison to emerging economies like China (which is at around 2 percent).
• Intellectual Property Right regime: There are two main areas of contention for the industry in India’s approach to intellectual property in biotech sector:
  • The first issue lies in Section 3(d) of the Patents (Amendment) Act, 2005, which sets a higher standard for patentability than mandated by TRIPS. The industry argues that India’s stricter standards for patents discourages innovation and dampens foreign investment.
  • The second issue is that of compulsory licensing, which gives the government power to suspend a patent in times of health emergencies. Although India has used this option only once, the industry feels that such regulations keep investors clear of Indian markets.
• Lack of Marketisation: Most of the early research funding, often provided by universities or the government, runs out before the marketisation phase, the funding for which is mostly provided by venture capitalists. This gap has a huge impact in commercialisation of innovative ideas.
• Public Awareness: Lack of public awareness of the modern tools of biotechnology and how it could improve our well-being, offer food and energy securities and help in preserving our environment.
• Less Lucrative: The number and quality of jobs offered by this sector is presently lesser than the work force supply available. This is making students less interested in this sector.
• Regulatory Authority: The Biotechnology Regulatory Authority of India Bill which envisions creating Regulatory body for uses of biotechnology products including genetically modified organisms is pending in the parliament.

• Genetic engineering involves the techniques to alter the chemistry of genetic material (DNA and RNA) and thus change the phenotype of the host organism.
• Asexual reproduction preserves the genetic information, while sexual reproduction permits variation.
• Traditional hybridisation procedures used in plant and animal breeding, very often lead to inclusion and multiplication of undesirable genes along with the desired genes.
• The techniques of genetic engineering which include creation of recombinant DNA, use of gene cloning and gene transfer, overcome this limitation and allows us to isolate and introduce only one or a set of desirable genes without introducing undesirable genes into the target organism.
• There are three basic steps in genetically modifying an organism —
  1. identification of DNA with desirable genes;
  2. introduction of the identified DNA into the host;
  3. maintenance of introduced DNA in the host and transfer of the DNA to its progeny.

A) Embryo Transfer

• Embryo Transfer Technology (ETT) is a technique used to increase the reproduction rate of cows and buffaloes. Embryo transfer simply means collection of an embryo from a donor female and its transfer to the uterus of a recipient female of the same species. It is used in diary industry for cattle heard improvement.

B) In-Vitro Fertilization

• IVF is an advanced reproductive technology that is used for production of embryos in in vitro condition for transfer. During IVF, using an ultrasound-guided needle, follicles of ovary of a cow/ buffalo are aspirated through the vaginal wall.A vacuum system is used to recover the contents of each follicle.
• Once all the follicles are aspirated from ovaries of cow/ buffalo. The oocytes are selected based on the cumulus cell layer. The recovered oocytes are washed before placing into maturation media to mature for 24 hours. Once they have matured, the oocytes will be fertilized with semen and the resulting embryos placed in an incubator for an additional seven days to grow. In between, the media is regularly replaced according to the stage of growth.
• After that the embryos are transferred into recipient animals that are approximately seven days post-heat, similar to traditional embryo transfer programs.

C) Cloning

• DNA which is somehow transferred into an alien organism would not be able to multiply itself in the progeny cells of the organism.
• But, when it gets integrated into the genome of the recipient, it may multiply and be inherited along with the host DNA. This is because the alien piece of DNA has become part of a chromosome, which has the ability to replicate.
• In a chromosome there is a specific DNA sequence called the origin of replication, which is responsible for initiating replication.
• Therefore, for the multiplication of any alien piece of DNA in an organism it needs to be a part of a chromosome(s) which has a specific sequence known as ‘origin of replication’.
• Thus, an alien DNA is linked with the origin of replication, so that, this alien piece of DNA can replicate and multiply itself in the host organism. This can also be called as cloning or making multiple identical copies of any template DNA.

• Recombinant DNA (rDNA) molecules are DNA molecules formed by laboratory methods of genetic recombination (such as molecular cloning) to bring together genetic material from multiple sources, creating sequences that would not otherwise be found in the genome.
• Recombinant DNA is possible because DNA molecules from all organisms share the same chemical structure. They differ only in the nucleotide sequence within that identical overall structure.
• In most cases, organisms containing recombinant DNA have apparently normal phenotypes. That is, their appearance, behaviour and metabolism are usually unchanged.

• The cutting of DNA at specific locations became possible with the discovery of the so-called ‘molecular scissors’- restriction enzymes.
• Restriction enzymes belong to a larger class of enzymes called nucleases. These are of two kinds; exonucleases and endonucleases.
• Exonucleases remove nucleotides from the ends of the DNA whereas, endonucleases make cuts at specific positions within the DNA.
• The cut piece of DNA was then linked with the plasmid DNA. These plasmid DNA act as vectors to transfer the piece of DNA attached to it.
• You probably know that mosquito acts as an insect vector to transfer the malarial parasite Into human body.
• In the same way, a plasmid can be used as vector to deliver an alien piece of DNA into the host organism.
• The linking of antibiotic resistance gene with the plasmid vector became possible with the enzyme DNA ligase, which acts on cut DNA molecules and joins their ends. This makes a new combination of circular autonomously replicating DNA created in vitro and is known as recombinant DNA.
• When this DNA is transferred into Escherichia coli, a bacterium closely related to Salmonella, it could replicate using the new host’s DNA polymerase enzyme and make multiple copies. The ability to multiply copies of antibiotic resistance gene in E. coli was called cloning of antibiotic resistance gene in E. coli.
• Recombinant DNA technological processes have made immense impact in the area of healthcare by enabling mass production of safe and more effective therapeutics.
• Since the recombinant therapeutics are identical to human proteins, they do not induce unwanted immunological responses and are free from risk of infection as was observed in case of similar products isolated from non-human sources. Human insulin is made in bacteria yet its structure is absolutely identical to that of the natural molecule.
• Transgenic animals are also used to understand how genes contribute to the development of a disease by serving as models for human diseases, such as cancer, cystic fibrosis, rheumatoid arthritis and Alzheimer’s.
• Gene therapy is the insertion of genes into an individual’s cells and tissues to treat diseases especially hereditary diseases. It does so by replacing a defective mutant allele with a functional one or gene targeting which involves gene amplification.
• Viruses that attack their hosts and introduce their genetic material into the host cell as part of their replication cycle are used as vectors to transfer healthy genes or more recently portions of genes.

A) Applications of Recombinant DNA Technology

• Recombinant DNA is widely used in biotechnology, medicine and research.
• Recombinant DNA is used to identify, map and sequence genes, and to determine their function.

B) Recombinant DNA is used to produce

• Recombinant human insulin,
• Recombinant human growth hormone,
• Recombinant blood clotting factor VIII,
• Recombinant hepatitis B vaccine,
• Insect-resistant crops etc.

• You may be surprised to know that we have learnt the lesson of transferring genes into plants and animals from bacteria and viruses which have known this for ages – how to deliver genes to transform eukaryotic cells and force them to do what the bacteria or viruses want.
• For example, Agrobacteriumtumefaciens, a pathogen of several dicot plants is able to deliver a piece of DNA known as ‘T-DNA’ to transform normal plant cells into a tumour and direct these tumour cells to produce the chemicals required by the pathogen.
• Similarly, retroviruses in animals have the ability to transform normal cells into cancerous cells.
• A better understanding of the art of delivering genes by pathogens in their eukaryotic hosts has generated knowledge to transform these tools of pathogens into useful vectors for delivering genes of interest to humans.
• The tumour inducing (Ti) plasmid of Agro bacterium tumefaciens has now been modified into a cloning vector which is no more pathogenic to the plants but is still able to use the mechanisms to deliver genes of our interest into a variety of plants.
• Similarly, retroviruses have also been disarmed and are now used to deliver desirable genes into animal cells.
• So, once a gene or a DNA fragment has been ligated into a suitable vector it is transferred into a bacterial, plant or animal host (where it multiplies).
• Plasmids and bacteriophages [vectors] have the ability to replicate within bacterial cells independent of the control of chromosomal DNA.

• Since DNA is a hydrophilic molecule, it cannot pass through cell membranes. In order to force bacteria to take up the plasmid, the bacterial cells must first be made ‘competent’ to take up DNA. Recombinant DNA can then be forced into such cells by incubating the cells with recombinant DNA on ice, followed by placing them briefly at 42⁰C (heat shock), and then putting them back on ice. This enables the bacteria to take up the recombinant DNA. This is not the only way to introduce alien DNA into host cells.
• In a method known as micro-injection, recombinant DNA is directly injected into the nucleus of an animal cell.
• In another method, suitable for plants, cells are bombarded with high velocity micro-particles of gold or tungsten coated with DNA in a method known as biolistics or gene gun.
• And the last method uses ‘disarmed pathogen’ vectors, which when allowed to infect the cell, transfer the recombinant DNA into the host.

• Biotechnology essentially deals with industrial scale production of biopharmaceuticals and biologicals using genetically modified microbes, fungi, plants and animals.
• The applications of biotechnology include therapeutics, diagnostics, genetically modified crops for agriculture, processed food, bioremediation, waste treatment, and energy production.

A) Cloning

• Cloning is the production of an exact copy of a cell, any other living part, or a complete organism.
• Cloning of an animal was successfully performed for the first time by Ian Wilmut and his colleagues at the Roslin Institute in Edinburgh, Scotland.
• They cloned successfully a sheep named Dolly. Dolly was born in 1996 and was the first mammal to be cloned.
• During the process of cloning Dolly, a cell was collected from the mammary gland of a female Finn Dorsett sheep. Simultaneously, an egg was obtained from a Scottish blackface ewe. The nucleus was removed from the egg. Then, the nucleus of the mammary gland cell from the Finn Dorsett sheep was inserted into the egg of the Scottish blackface ewe whose nucleus had been removed. The egg thus produced was implanted into the Scottish blackface ewe.
•  Development of this egg followed normally and finally Dolly was born. Though Dolly was given birth by the Scottish blackface ewe, it was found to be absolutely identical to the Finn Dorsett sheep from which the nucleus was taken. Since the nucleus from the egg of the Scottish blackface ewe was removed, Dolly did not show any character of the Scottish blackface ewe.

• Dolly was a healthy clone of the Finn Dorsett sheep and produced several offspring of her own through normal sexual means.
• Since Dolly, several attempts have been made to produce cloned mammals. However, many dies before birth or die soon after birth. The cloned animals are many-a-time found to be born with severe abnormalities.

B) Biotechnological applications in agriculture

• Let us take a look at the three options that can be thought for increasing food production
  • agro-chemical based agriculture;
  • organic agriculture; and
  • Genetically engineered crop-based agriculture.
• Plants, bacteria, fungi and animals whose genes have been altered by manipulation are called Genetically Modified Organisms (GMO). GM plants have been useful in many ways. Genetic modification has:
  • Made crops more tolerant to abiotic stresses (cold, drought, salt, heat).
  • Reduced reliance on chemical pesticides (pest-resistant crops).
  • Helped to reduce postharvest losses.
  • Increased efficiency of mineral usage by plants (this prevents early exhaustion of fertility of soil).
  • Enhanced nutritional value of food, e.g., Vitamin ‘A’ enriched rice.

• GM crops were grown in 28 countries and on 179.7 million hectares – that is over 10% of the world’s arable land and equivalent to seven times the land area of the UK. The USA, Brazil and Argentina are the leading producers. There are currently no GM crops being grown commercially in the UK although scientists are carrying out controlled trials.
• The GM crops grown commercially included: potato (USA), squash/pumpkin (USA) alfalfa (USA), aubergine (Bangladesh), sugar beet (USA, Canada), papaya (USA and China), oilseed rape (4 countries), maize (corn) (17 countries), soya beans (11 countries) and cotton (15 countries).

• GM crops were first introduced in the USA in 1994 with the FlavrSavr tomato, which had been genetically modified to slow its ripening process, delaying softening and rotting.
• The farming of GM crops has massively increased since the mid-1990s. In 1996, just 1.7 million hectares (MHa) were planted with GM crops globally but by 2015, 179.7 million hectares of GM crops were grown, accounting for over 10% of the world’s arable land.
• The top GM crop grown in 2015 was soybean (92.1 MHa), followed by maize (53.6 Mha), then cotton (24 Mha) and oilseed rape (canola) (8.5 Mha). GM crops made up 29% of the world’s maize produce, and almost a quarter of the world’s oilseed rape that year.

>Indian Scenario

• India has commercialized only one GE crop, the Bt cotton with the Cry 1 Ac gene.
• India is at the 4th global position in hectarage under GM crops.
• Bt cotton greatly contributed to a significant increase in farm income and India’s transformation from a cotton importer into an exporter.
• The area under Bt cotton seeds is rising, official data for the 2018 – 19 kharif season reveals that 88.27 per cent of the 122.38 lakh hectares cultivation is under Bt cotton of all varieties
• GM crops and products are stringently
• Regulated for their efficacy, biosafety, environmental safety and socio-economic benefits, through mandatory rules and procedures.
• Benefits of GM Crops
• Increased crop resilience: Better tolerance to harsh climatic conditons like, heat, drought salinity etc.
• It also prevents of loss species to endemic disease.
• In addition to these uses, GM has been used to create tailor-made plants to supply alternative resources to industries, in the form of starches, fuels and pharmaceuticals.
• Socio- economic benefits: Improved agricultural performance (yields) with less labour input and less cost input.
• GM crops provide an opportunity to bring an “evergreen” revolution that benefits landless, marginal and small farmers in India.
• Reduced usage of pesticides and herbicides
• Reduction in imports: GM crops can help provide the next great leap by helping to eliminate import of edible oil, Pulses, etc.
• Food security: GM crops offer a solution to further enhance the India’s food security needs. Food with more desirable traits can be produced.

• Monopoly: Introduction of GM crop is a method by which large seed-producing companies attempt to monopolise the markets. GM seeds contain ‘terminatortechnology’ meaning they have been genetically modified so that resulting crops do not produce viable seeds of their own.
• Outcrossing: The migration of genes from GM plants into conventional crops or wild species may have an indirect effect on food safety and food security.
• Decline in yield: There has been witnessed a decline/stagnation in yield after few years with respect to many GM crops which in turn leads to diminishing returns.
• Concerns for human health: Gene transfer from GM foods to humans can be problematic if the transferred genetic material adversely affects human health. This would be particularly relevant if antibiotic resistance genes were to be transferred.
• Allergenicity: Because protein sequences are changed with the addition of new genetic material, there is concern that the engineered or modified organism could produce known or unknown allergens.
• Resistance developed by Pathogens: There is always a concern of pathogens becoming resistant to the toxins produced by GM crops. For example, the pink bollworm has grown resistant to the toxins produced by BT cotton seed of Monsanto.
• Concerns for the environment: The susceptibility of non-target organisms (e.g. bees and butterflies) and the loss of biodiversity of crop/plant species remains a concern.
• Toxins produced in GM crops are present in every part of the plant, so when the parts that have not been harvested decompose, a considerable amount of the toxin may reach the soil/water table.

• Possibility of data manipulation: The GEAC does not conduct the closed field trials on their own but are solely dependent on the data provided to them by the technology developer making it susceptible to manipulations and fudging the data.
• Concerns regarding GEAC: Issues such as adhocism in its constitution, criteria adopted for selection of its members, dominance of bureaucrats, no representation from civil society or states where Bt Cotton has been introduced, head not being from field of Biotechnology etc. remain.
• Functioning of DLCs: The presence of District Level Committee (DLC) which regulates GM crop at the ground l evel is hardly felt in any of the States.
• Negative public perception: Public attention has focused on the risk side of the risk-benefit equation owing to lack of transparency and ignorance about the scientific facts related to GM crops. Moreover, India has imported edible GM soybean and canola so the resistance to growing the same is contradictory..
• Bt toxin is produced by a bacterium called Bacillus thuringiensis (Bt for short).
• Some strains of Bacillus thuringiensis produce proteins that kill certain insects such as tobacco budworm, armyworm, beetles and dipterans flies, mosquitoes.
• Why does this toxin not kill the Bacillus? Actually, the Bt toxin protein exist as inactive protoxins but once an insect ingest the inactive toxin, it is converted into an active form of toxin due to the alkaline pH of the gut which solubilise the crystals.
• Bt toxin gene has been cloned from the bacteria and been expressed in plants to provide resistance to insects without the need for insecticides; in effect created a bio-pesticide.
• Examples are Bt cotton, Bt corn, rice, tomato, potato and soyabean etc.

• The manipulation of living organisms by the human race cannot go on any further, without regulation. Some ethical standards are required to evaluate the morality of all human activities that might help or harm living organisms.
• Going beyond the morality of such issues, the biological significance of such things is also important. Genetic modification of organisms can have unpredictable results when such organisms are introduced into the ecosystem.
• Therefore, the Indian Government has set up organisations such as GEAC (Genetic Engineering Approval Committee), which will make decisions regarding the validity of GM research and the safety of introducing GM-organisms for public services.
• The modification/usage of living organisms for public services (as food and medicine sources, for example) has also created problems with patents granted for the same.
• There is growing public anger that certain companies are being granted patents for products and technologies that make use of the genetic materials, plants and other biological resources that have long been identified, developed and used by farmers and indigenous people of a specific region/country.
• Rice is an important food grain, the presence of which goes back thousands of years in Asia’s agricultural history. There are an estimated 200,000 varieties of rice in India alone. The diversity of rice in India is one of the richest in the world.
• Basmati rice is distinct for its unique aroma and flavour and 27 documented varieties of Basmati are grown in India. There is reference to Basmati in ancient texts, folklore and poetry, as it has been grown for centuries.
• In 1997, an American company got patent rights on Basmati rice through the US Patent and Trademark Office. This allowed the company to sell a ‘new’ variety of Basmati, in the US and abroad. This ‘new’ variety of Basmati had actually been derived from Indian farmer’s varieties.
• Indian Basmati was crossed with semi-dwarf varieties and claimed as an invention or a novelty. The patent extends to functional equivalents, implying that other people selling Basmati rice could be restricted by the patent.
• Several attempts have also been made to patent uses, products and processes based on Indian traditional herbal medicines, e.g., turmeric neem. If we are not vigilant and we do not immediately counter these patent applications, other countries/individuals may encash on our rich legacy and we may not be able to do anything about it.
• Biopiracy is the term used to refer to the use of bio-resources by multinational companies and other organisations without proper authorisation from the countries and people concerned without compensatory payment.
• Most of the industrialised nations are rich financially but poor in biodiversity and traditional knowledge. In contrast the developing and the underdeveloped world is rich in biodiversity and traditional knowledge related to bio-resources.
• Traditional knowledge related to bio-resources can be exploited to develop modern applications and can also be used to save time, effort and expenditure during their commercialisation.
• There has been growing realisation of the injustice, inadequate compensation and benefit sharing between developed and developing countries. Therefore, some nations are developing laws to prevent such unauthorised exploitation of their bio-resources and traditional knowledge.
• The Indian Parliament has recently cleared the second amendment of the Indian Patents Bill, that takes such issues into consideration, including patent terms emergency provisions and research and development initiative.

• The recombinant DNA technological processes have made immense impact in the area of healthcare by enabling mass production of safe and more effective therapeutic drugs.
• Further, the recombinant therapeutics do not induce unwanted immunological responses as is common in case of similar products isolated from non-human sources.
• At present, about 30 recombinant therapeutics have been approved for human-use the world over. In India, 12 of these are presently being marketed.

A) Genetically Engineered Insulin

• Management of adult-onset diabetes is possible by taking insulin at regular time intervals. What would a diabetic patient do if enough human-insulin was not available?
• If you discuss this, you would soon realise that one would have to isolate and use insulin from other animals. Would the insulin isolated from other animals be just as effective as that secreted by the human body itself and would it not elicit an immune response in the human body?
• Now, imagine if bacterium were available that could make human insulin. Suddenly the whole process becomes so simple. You can easily grow a large quantity of the bacteria and make as much insulin as you need.
• Think about whether insulin can be orally administered to diabetic people or not. Why?
• Insulin used for diabetes was earlier extracted from pancreas of slaughtered cattle and pigs.
• Insulin from an animal source, though caused some patients to develop allergy or other types of reactions to the foreign protein.
• Insulin consists of two short polypeptide chains: chain A and chain B, that are linked together by disulphide
• In mammals, including humans, insulin is synthesised as a pro-hormone (like a pro-enzyme, the pro-hormone also needs to be processed before it becomes a fully mature and functional hormone) which contains an extra stretch called the C peptide. This C peptide is not present in the mature insulin and is removed during maturation into insulin.The main challenge for production of insulin using rDNA techniques was getting insulin assembled into a mature form.
• In 1983, Eli Lilly an American company prepared two DNA sequences corresponding to A and B, chains of human insulin and introduced them in plasmids of E. coli to produce insulin chains. Chains A and B were produced separately, extracted and combined by creating disulfide bonds to form human insulin.

B) Gene Therapy

• If a person is born with a hereditary disease, can a corrective therapy be taken for such a disease? Gene therapy is an attempt to do this.
• Gene therapy is a collection of methods that allows correction of a gene defect that has been diagnosed in a child/embryo.
• Here genes are inserted into a person’s cells and tissues to treat a disease. Correction of a genetic defect involves delivery of a normal gene into the individual or embryo to take over the function of and compensate for the non-functional gene.
• The first clinical gene therapy was given in 1990 to a 4-year old girl with adenosine deaminase (ADA) This enzyme is crucial for the immune system to function.
• The disorder is caused due to the deletion of the gene for adenosine deaminase.
• In some children ADA deficiency can be cured by bone marrow transplantation; in others it can be treated by enzyme replacement therapy, in which functional ADA is given to the patient by injection.
• But the problem with both of these approaches that they are not completely curative.
• As a first step towards gene therapy, lymphocytes from the blood of the patient are grown in a culture outside the body. A functional ADA cDNA (using a retroviral vector) is then introduced into these lymphocytes, which are subsequently returned to the patient.
• However, as these cells are not immortal, the patient requires periodic infusion of such genetically engineered lymphocytes.
• However, if the gene isolate from marrow cells producing ADA is introduced into cells at early embryonic stages, it could be a permanent cure.

C) Molecular Diagnosis

• You know that for effective treatment of a disease, early diagnosis and understanding its pathophysiology is very important.
• Using conventional methods of diagnosis (serum and urine analysis, etc.) early detection is not possible.
• Recombinant DNA technology, Polymerase Chain Reaction (PCR) and Enzyme Linked Immuno-sorbent Assay (ELISA) are some of the techniques that serve the purpose of early diagnosis.
• Presence of a pathogen (bacteria, viruses, etc.) is normally suspected only when the pathogen has produced a disease symptom. By this time the concentration of pathogen is already very high in the body.
• However, very low concentration of a bacteria or virus (at a time when the symptoms of the disease are not yet visible) can be detected by amplification of their nucleic acid by PCR.
• PCR is now routinely used to detect HIV in suspected AIDS patients. It is being used to detect mutations in genes in suspected cancer patients too. It is a powerful technique to identify many other genetic disorders.
• ELISA is based on the principle of antigen-antibody interaction. Infection by pathogen can be detected by the presence of antigens (proteins, glycoproteins, etc.) or by detecting the antibodies synthesised against the pathogen.

D) Transgenic animals

• Animals that have had their DNA manipulated to possess and express an extra (foreign) gene are known as transgenic animals.
• Transgenic rats, rabbits, pigs, sheep, cows and fish have been produced, although over 95 per cent of all existing transgenic animals are mice.
• Why are these animals being produced? How can man benefit from such modifications? Let us try and explore some of the common reasons.
• Normal physiology and development: Transgenic animals can be specifically designed to allow the study of how genes are regulated, and how they affect the normal functions of the body and its development, e.g., study of complex factors involved in growth such as insulin-like growth factor. By introducing genes from other species that alter the formation of this factor and studying the biological effects that result, information is obtained about the biological role of the factor in the body.
• Study of disease: Many transgenic animals are designed to increase our understanding of how genes contribute to the development of disease. These are specially made to serve as models for human diseases so that investigation of new treatments for diseases is made possible. Today transgenic models exist for many human diseases such as cancer, cystic fibrosis, rheumatoid arthritis and Alzheimer’s.
• Biological products: Medicines required to treat certain human diseases can contain biological products, but such products are often expensive to make. Transgenic animals that produce useful biological products can be created by the introduction of the portion of DNA (or genes) which codes for a particular product such as human protein. Similar attempts are being made for treatment of phenylketonuria (PKU) and cystic fibrosis. In 1997, the first transgenic cow, Rosie, produced human protein-enriched milk (2.4 grams per litre). The milk contained the human alpha-lactalbumin and was nutritionally a more balanced product for human babies than natural cow-milk.
• Vaccine safety: Transgenic mice are being developed for use in testing the safety of vaccines before they are used on humans. Transgenic mice are being used to test the safety of the polio vaccine. If successful and found to be reliable, they could replace the use of monkeys to test the safety of batches of the vaccine.
• Chemical safety testing: This is known as toxicity/safety testing. The procedure is the same as that used for testing toxicity of drugs. Transgenic animals are made that carry genes which make them more sensitive to toxic substances than non-transgenic animals. They are then exposed to the toxic substances and the effects studied. Toxicity testing in such animals will allow us to obtain results in less time.

• Fortification is the practice of increasing the content of an essential micronutrient, i.e. vitamins and minerals (including trace elements) in a food.
• Biofortification is fortification done through agronomic practices (soil management and crop production), conventional plant breeding, or modern biotechnology.
• In conventional fortification nutrient levels are increased during processing of the crops.
• Biofortification increases nutrient levels in crops during plant growth.
• Biofortification is better than conventional fortification as it is easy to implement.
• Biofortification may therefore present a way to reach populations where supplementation and conventional fortification activities may be difficult to implement and/or limited.
• Examples of biofortification projects include:
  • iron-biofortification of rice, beans, sweet potato, cassava and legumes;
  • zinc-biofortification of wheat, rice, beans, sweet potato and maize;
  • provitamin A carotenoid-biofortification of sweet potato, maize and cassava; and
  • amino acid and protein-biofortification of sorghum and cassava.
• Examples of biofortified crops in India
  • Pearl millet (iron), wheat (zinc), sorghum (iron), rice (zinc), cowpeas (iron) and lentils (iron and zinc).
  • Dhanshakti (biofortified pearl millet or bajra) is the first iron biofortified crop to be officially released in India.
• Coloured Wheat
  • Coloured wheat is developed by Mohali’s National Agri-Food Biotechnology Institute (NABI).
  • The three coloured varieties are purple, black and blue wheat.
  • NABI comes under the Union Ministry of Science and Technology.
  • Food Safety and Standards Authority of India (FSSAI) gave its nod for human consumption of coloured wheat.
  • The wheat gets its colour from anthocyanin.
  • While normal wheat has 5 ppm of anthocyanin, the purple wheat has 40 ppm.
  • Anthocyanin is a pigment that gives colour to fruits such as blueberries and jamun.
  • Anthocyanin is also an antioxidant (can reduce chances of cardiovascular diseases, diabetes and obesity).
  • Coloured wheat can give the requisite quantities of anthocyanin without the fear of high blood sugar.
  • The black one possesses the highest amount of anthocyanin, followed by blue and purple wheat.
  • Coloured wheat is also biofortified with zinc and hence can fight malnutrition among children.
  • One acre gives about 20 quintals of coloured wheat at best — four quintals less than the normal variety.
  • All three varieties of wheat are now being tested by the Indian Council of Agriculture Research (ICAR).